Orchestra BioMed Holdings, Inc. (OBIO)
Fuera de horario:
Orchestra BioMed Holdings, Inc.
150 Union Square Drive
New Hope, PA 18938
United States
212 862 5797
https://orchestrabiomed.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 56
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. David P. Hochman | Founder, Chairman of the Board of Directors & CEO | 942k | N/D | 1975 |
| Mr. Darren R. Sherman | Founder, President, COO & Director | 787k | N/D | 1971 |
| Mr. Andrew Lawrence Taylor M.B.A. | Chief Financial Officer | 500.02k | N/D | 1971 |
| Mr. William Reed Little | Executive VP of Corporate Development & Strategy | N/D | N/D | 1972 |
| Dr. Yuval Hay Mika D.Sc, Ph.D. | GM & CTO of Bioelectronic Therapies | N/D | N/D | 1959 |
| Dr. George Papandreou Ph.D. | GM & Senior VP of Focal Therapies | N/D | N/D | 1965 |
| Dr. Hans-Peter Stoll M.D., Ph.D. | Chief Clinical Officer | N/D | N/D | N/D |
| Dr. Avraham Matityahu Fischer M.D. | Senior Vice President of Medical Affairs & Innovation | N/D | N/D | 1956 |
| Mr. Bob Laughner | Senior Vice President of Regulatory & Quality | N/D | N/D | N/D |
| Mr. Juan Lorenzo | Senior Vice President of Product Development | N/D | N/D | N/D |
Descripción
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
Gestión corporativa
La calificación ISS Governance QuickScore de Orchestra BioMed Holdings, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
